← Back to Search

Hormone Therapy

Transdermal Estrogen for Anorexia Nervosa

Phase 2
Recruiting
Led By Pouneh Fazeli, MD
Research Sponsored by Pouneh K. Fazeli, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female
19-45 years of age
Timeline
Screening 3 days
Treatment 18 months
Follow Up 1 day
Awards & highlights

Study Summary

This trial looks at whether using estrogen can help with low bone mass in women with anorexia nervosa.

Who is the study for?
This trial is for adult women aged 19-45 with anorexia nervosa, specifically those who are underweight according to specific tables and have low bone mass. Participants must not be pregnant or planning pregnancy soon, should not have a history of certain blood or bone disorders, no recent use of medications affecting bone metabolism, and no severe illnesses like diabetes or untreated thyroid issues.Check my eligibility
What is being tested?
The study is testing the effects of transdermal estrogen patches compared to placebo on improving bone density in women with anorexia nervosa. It's a randomized trial meaning participants will be randomly assigned to either the treatment group receiving estrogen or the control group receiving a placebo.See study design
What are the potential side effects?
Potential side effects from transdermal estrogen may include skin irritation at the patch site, changes in mood or libido, headaches, nausea, menstrual irregularities for those not experiencing amenorrhea and possibly increased risk of blood clots.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below
Select...
I am female.
Select...
I am between 19 and 45 years old.
Select...
I have been diagnosed with anorexia nervosa.
Select...
I am female.
Select...
I am between 19 and 45 years old.
Select...
I have been diagnosed with anorexia nervosa.

Timeline

Screening ~ 3 days
Treatment ~ 18 months
Follow Up ~1 day
This trial's timeline: 3 days for screening, 18 months for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in bone mineral density at 18 months
Secondary outcome measures
Structure of neck of femur
Change in bone mineral density at hip at 18 months
Change in estimated bone strength at 18 months
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transdermal estrogen/progesteroneExperimental Treatment1 Intervention
Transdermal estradiol (0.045mg)/levonorgestrel (0.015mg) patch applied weekly for 18 months
Group II: PlaceboPlacebo Group1 Intervention
Placebo patch applied weekly for 18 months

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

Pouneh K. Fazeli, MDLead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,964 Previous Clinical Trials
2,674,664 Total Patients Enrolled
4 Trials studying Anorexia Nervosa
375 Patients Enrolled for Anorexia Nervosa
Pouneh Fazeli, MDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
90 Total Patients Enrolled

Media Library

Transdermal estrogen (Hormone Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03875378 β€” Phase 2
Anorexia Nervosa Research Study Groups: Placebo, Transdermal estrogen/progesterone
Anorexia Nervosa Clinical Trial 2023: Transdermal estrogen Highlights & Side Effects. Trial Name: NCT03875378 β€” Phase 2
Transdermal estrogen (Hormone Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03875378 β€” Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study allow for elderly participants?

"The age limit for this clinical trial is set at 45 years old. If you are younger than 19 or older than 44, there are other ongoing studies (44 for people under 18 and 53 for seniors) that might be a better fit."

Answered by AI

Could I possibly be a candidate for this research project?

"Currently, this anorexia nervosa study is looking for 66 female patients aged between 19-45 years old that meet the DSM-5 psychiatric criteria for anorexia nervosa. Furthermore, these individuals must have a T-score of -1.0 or lower at the hip or spine and amenorrhea. Lastly, candidates must not exceed 85% of their ideal body weight as defined by the 1983 Metropolitan Life Insurance Height and Weight Tables"

Answered by AI

Why is Transdermal estrogen commonly given to patients?

"Transdermal estrogen is most commonly used to treat amenorrhea, or the absence of a menstrual period, in women who have not menstruated for at least 6 months. It can also be used to alleviate other conditions like hypoestrogenism and menopausal vasomotor symptoms."

Answered by AI

How large is the sample size for this research project?

"That is accurate. The clinicaltrials.gov website contains information confirming that this study, which was first posted on 8/28/2020, is still recruiting patients. 66 individuals are needed at a single site for the trial."

Answered by AI

Has Transdermal estrogen received government sanctioning?

"Transdermal estrogen received a 2 for safety. This is due to the fact that it is still in Phase 2 trials, meaning that while there are studies supporting its safety, none have been done yet to show if it effective."

Answered by AI

Is this study still looking for participants?

"The trial is still recruiting patients, as seen on clinicaltrials.gov. The listing for this experiment was first put up on August 28th 2020 and has been updated as recently as May 5th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
Texas
How old are they?
18 - 65
What site did they apply to?
University of Pittsburgh School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I have had anorexia for 23 years and have not had my period for 5 years. Recent bone density results have me at the early stages of osteoporosis. My doctor is wonderful but her clients are generally on the younger side of the spectrum so she is not well-versed in options for someone who is closer to menopause. I am 45.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Phone Call
Email
Most responsive sites:
  1. University of Pittsburgh School of Medicine: < 48 hours
Average response time
  • < 2 Days
~7 spots leftby Sep 2024